Mr.

SHUBHANKAR RANA Reference: SELF VID: 230111503392206

Sample Collected At: Registered On:
PROMISO HEALTH PRIVATE LIMITED - 09/01/2024 02:10 PM
PID NO: P33723516773199 CREDIT Collected On:
B-23, H K ARCADE 1ST, FLOOR 1B,
Age: 22 Year(s) Sex: Male MAHADEAVAPURA POST, I T I 09/01/2024 2:08PM
INDUSTRIAL AREA, Reported On:
Sample Processed At: Metropolis 09/01/2024 05:50 PM
Healthcare Ltd E-21, B1 Mohan Co-op
Ind Estate New Delhi-110044

Haemogram

Investigation Observed Value Unit Biological Reference Interval

Erythrocytes
Erythrocyte (RBC) Count 5.08 mill/cu.mm 4.7-6.0
Haemoglobin (Hb) 16.3 g/dL 13.5-18
HCT(Hematocrit) 47.4 % 42-52
MCV (Mean Corpuscular Volume) 93.4 fL 78-100
MCH (Mean Corpuscular Hb) 32.0 pg 27-31
MCHC (Mean Corpuscular Hb Concn.) 34.3 g/dL 32-36
RDW (Red Cell Distribution Width) 14.0 CV% 11.5-14.0
Leucocytes
Total Leucocytes (WBC) count 7000 cells/cu.mm 4300-10300
Absolute Neutrophils Count 3150 /c.mm 2000-7000
Absolute Lymphocyte Count 3220 /c.mm 1000-3000
Absolute Monocyte Count 490 /c.mm 200-1000
Absolute Eosinophils Count 140 /c.mm 20-500
Absolute Basophils Count 0 /c.mm 20-100
Neutrophils 45 % 40-80
Lymphocytes 46 % 20-40
Monocytes 7 % 2.0-10
Eosinophils 2 % 1-6
Basophils 0 % 0-2
Platelets
Platelet count 240 10^3 / µl 150-450
MPV (Mean Platelet Volume) 9.4 fL 6-9.5
PCT ( Platelet Haematocrit) 0.22 % 0.2-0.5
PDW (Platelet Distribution Width) 17.4 % 9-17
EDTA Whole Blood : Test is done on Automated Five Part Cell Counter. Hemoglobin is measured by Spectrophotometry method.
WBC, RBC and Platelet Count are measured by Coulter Principle (Impedance Method). WBC Differential is done by VCS Method.
MCV and RDW are derived from RBC histogram. MPV and PDW are derived from Platelet histogram. Calculated Parameters are:
HCT, MCH, MCHC, PCT and Absolute WBC counts. All abnormal hemogram are reviewed and confirmed microscopically.
Differential count is based on approximately 10,000 cells.

Page 1 of 6
Dr. Kush Kumar Singh
M.D (Pathology)
(DMC Reg. No. - 39780)

48 of 60

AALCP8413E
 Mr. SHUBHANKAR RANA Reference: SELF VID: 230111503392206
Sample Collected At: Registered On:
PROMISO HEALTH PRIVATE LIMITED - 09/01/2024 02:10 PM
PID NO: P33723516773199 CREDIT Collected On:
B-23, H K ARCADE 1ST, FLOOR 1B,
Age: 22 Year(s) Sex: Male MAHADEAVAPURA POST, I T I 09/01/2024 2:08PM
INDUSTRIAL AREA, Reported On:
Sample Processed At: Metropolis 09/01/2024 05:50 PM
Healthcare Ltd E-21, B1 Mohan Co-op
Ind Estate New Delhi-110044

HbA1c Glycated Haemoglobin

(EDTA Whole Blood)

Investigation Observed Value Unit Biological Reference Interval

HbA1C- Glycated Haemoglobin 5.1 % Non-diabetic: <= 5.6
(HPLC) Pre-diabetic: 5.7-6.4
Diabetic: >= 6.5
Estimated Average Glucose (eAG) 99.67 mg/dL
(Calculated)

Interpretation & Remark:

1. HbA1c is used for monitoring diabetic control. It reflects the estimated average glucose (eAG).
2. HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines 2022, for diagnosis of
diabetes using a cut-off point of 6.5%.
3. Trends in HbA1c are a better indicator of diabetic control than a solitary test.
4. Low glycated haemoglobin(below 4%) in a non-diabetic individual are often associated with systemic inflammatory diseases,
chronic anaemia(especially severe iron deficiency & haemolytic), chronic renal failure and liver diseases. Clinical correlation
suggested.
5. To estimate the eAG from the HbA1C value, the following equation is used: eAG(mg/dl) = 28.7*A1c-46.7
6. Interference of Haemoglobinopathies in HbA1c estimation.
A. For HbF > 25%, an alternate platform (Fructosamine) is recommended for testing of HbA1c.
B. Homozygous hemoglobinopathy is detected, fructosamine is recommended for monitoring diabetic status
C. Heterozygous state detected (D10/ turbo is corrected for HbS and HbC trait).

7. In known diabetic patients, following values can be considered as a tool for monitoring the glycemic control. Excellent
Control - 6 to 7 %, Fair to Good Control - 7 to 8 %, Unsatisfactory Control - 8 to 10 % and Poor Control - More than 10 % .

Note : Hemoglobin electrophoresis (HPLC method) is recommended for detecting hemoglobinopathy.

Tests marked with NABL symbol are accredited by NABL vide Certificate no MC-2676; Validity till 04-04-2024

Page 2 of 6 Dr. Kush Kumar Singh

M.D (Pathology)
(DMC Reg. No. - 39780)

49 of 60

AALCP8413E
 Mr. SHUBHANKAR RANA Reference: SELF VID: 230111503392206
Sample Collected At: Registered On:
PROMISO HEALTH PRIVATE LIMITED -
09/01/2024 02:10 PM
CREDIT
PID NO: P33723516773199 B-23, H K ARCADE 1ST, FLOOR 1B, Collected On:
Age: 22 Year(s) Sex: Male MAHADEAVAPURA POST, I T I 09/01/2024 2:08PM
INDUSTRIAL AREA, Reported On:
Sample Processed At: Metropolis
Healthcare Ltd E-21, B1 Mohan Co-op Ind 09/01/2024 05:50 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

CAT 5 + HBA1C
Alkaline Phosphatase 90 U/L 40-129
(Serum,para-Nitrophenyl-phosphate)
BilirubinTotal, Direct, IndirectSerum
Bilirubin-Total 0.76 mg/dL 0.2-1.2
(Serum,Diazotized Sulfanilic Acid (Modified Jendrassik
& Grof))
Bilirubin-Direct 0.26 mg/dL 0.0-0.5
(Serum,Diazotized Sulfanilic Acid (Modified Jendrassik
& Grof))
Bilirubin- Indirect 0.50 mg/dL 0.1-1.0
(Serum,Calculated)
Gamma GT (GGTP) 16 U/L 12-64
(Serum,L-Gamma-glutamyl-3-carboxy -4 - nitroanalyte
substrate, IFCC)
Proteins
Total Protein 8.07 g/dL 6.4-8.3
(Serum,Biuret)
Albumin 5.04 g/dL 3.5-5.2
(Serum,Bromocresol green)
Globulin 3.03 g/dL 1.8-3.6
(Serum,Calculated)
A/G Ratio 1.66 1.1-2.2
(Serum,Calculated)
SGOT/SGPT Ratio
SGOT (AST) 17.9 U/L 0-35
(Serum,NADH without P5P)
SGPT (ALT) 18.3 U/L 0-45
(Serum,NADH without P5P)
SGOT(AST)/SGPT(ALT) RATIO 0.98
(Serum)
HDL Cholesterol 46.6 mg/dL Major risk factor for heart
(Serum,Accelerator Selective Detergent) disease: <= 40
Negative risk factor for heart
disease: >= 60
Creatinine 1.11 mg/dL 0.70-1.20
(Serum,Modified Jaffe)
BUN-Blood Urea Nitrogen 9.0 mg/dL 6-20
(Serum,Urease)
Remark: In blood, Urea is usually reported as BUN and expressed in mg/dl. BUN mass units can be converted to urea mass units
by multiplying by 2.14.

Cholesterol (Total) 207.5 mg/dL Desirable: < 200

(Serum,Cholesterol Oxidase- Peroxidase) Borderline High: 200-239
High: >= 240

Dr. Kush Kumar Singh

M.D (Pathology)
Page 3 of 6 (DMC Reg. No. - 39780)

50 of 60

AALCP8413E
 Mr. SHUBHANKAR RANA Reference: SELF VID: 230111503392206
Sample Collected At: Registered On:
PROMISO HEALTH PRIVATE LIMITED -
09/01/2024 02:10 PM
CREDIT
PID NO: P33723516773199 B-23, H K ARCADE 1ST, FLOOR 1B, Collected On:
Age: 22 Year(s) Sex: Male MAHADEAVAPURA POST, I T I 09/01/2024 2:08PM
INDUSTRIAL AREA, Reported On:
Sample Processed At: Metropolis
Healthcare Ltd E-21, B1 Mohan Co-op Ind 09/01/2024 05:50 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

Triglycerides level 112.9 mg/dL Normal: < 150
(Serum,Glycerol Phosphate Oxidase) Borderline High: 150-199
High: 200-499
Very High: >= 500
HBsAg Screening Non Reactive(0.01) IU/mL Non Reactive: < 0.05
(Serum,CMIA) Reactive: >= 0.05
All Reactive results must be confirmed by Neutralizing confirmatory test or by HBV DNA detection assay.

Abbreviation :
CMIA : Chemiluminescence Microparticle Immunoassay
HBsAg : Hepatitis B Surface Antigen

HIV-DUO (IV th Generation test) Non Reactive(0.15) S/CO Non Reactive: < 1
(Serum,CMIA) Reactive: >= 1

Remarks :

1. HIV - DUO determines the presence of HIV p24 antigen and antibodies to HIV -1 group and HIV-2.
2. It is a screening test. All Reactive results are crosschecked by immunochromatography method and ELFA, reported as per
NACO guidelines.
3. All Reactive results need to be confirmed by alternate methods, like Western Blot.

Abbreviation :
CMIA : Chemiluminescence Microparticle Immunoassay

ESR - Erythrocyte Sedimentation Rate 7 mm/hr <= 14

(EDTA Whole Blood)

Method: Automated, based on Westergren Method

Interpretation:

1. It indicates presence and intensity of an inflammatory process, never diagnostic of a specific disease. Changes are more
significant than a single abnormal test.
2. It is a prognostic test and used to monitor the course or response to treatment of diseases like tuberculosis, bacterial
endocarditis, acute rheumatic fever, rheumatoid arthritis, SLE, Hodgkins disease, temporal arteritis, polymyalgia rheumatica.
3. It is also increased in pregnancy, multiple myeloma, menstruation, and hypothyroidism.

Dr. Kush Kumar Singh

M.D (Pathology)
Page 4 of 6 (DMC Reg. No. - 39780)

51 of 60

AALCP8413E
 Mr. SHUBHANKAR RANA Reference: SELF VID: 230111503392206
Sample Collected At: Registered On:
PROMISO HEALTH PRIVATE LIMITED -
09/01/2024 02:10 PM
CREDIT
PID NO: P33723516773199 B-23, H K ARCADE 1ST, FLOOR 1B, Collected On:
Age: 22 Year(s) Sex: Male MAHADEAVAPURA POST, I T I 09/01/2024 2:08PM
INDUSTRIAL AREA, Reported On:
Sample Processed At: Metropolis
Healthcare Ltd E-21, B1 Mohan Co-op Ind 09/01/2024 05:50 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

Glucose fasting 93.0 mg/dL Normal: 70-99
(Plasma-F,Hexokinase) Impaired Tolerance: 100-125
Diabetes mellitus: >= 126
(on more than one occasion)
(American diabetes association
guidelines 2021)

Tests marked with NABL symbol are accredited by NABL vide Certificate no MC-2676; Validity till 04-04-2024

Page 5 of 6

Dr. Kush Kumar Singh

M.D (Pathology)
(DMC Reg. No. - 39780) 52 of 60

AALCP8413E
 Mr. SHUBHANKAR RANA Reference: SELF VID: 230111503392206
Sample Collected At: Registered On:
PROMISO HEALTH PRIVATE LIMITED - 09/01/2024 02:10 PM
PID NO: P33723516773199 CREDIT Collected On:
B-23, H K ARCADE 1ST, FLOOR 1B,
Age: 22 Year(s) Sex: Male MAHADEAVAPURA POST, I T I 09/01/2024 2:08PM
INDUSTRIAL AREA, Reported On:
Sample Processed At: Metropolis 09/01/2024 05:50 PM
Healthcare Ltd E-21, B1 Mohan Co-op
Ind Estate New Delhi-110044

ROUTINE EXAMINATION URINE

Investigation Observed Value Unit Biological Reference Interval
CAT 5 + HBA1C
General Examination
Colour Pale Yellow Pale Yellow
Transparency (Appearance) Clear Clear
Reaction (pH) 6.5 4.5-7.0
Specific gravity 1.015 1.005-1.030
Chemical Examination
Urine Protein (Albumin) Absent Absent
Urine Ketones (Acetone) Absent Absent
Urine Glucose (sugar) Absent Absent
Bile pigments Absent Absent
Bile salts Absent Absent
Urobilinogen Normal Normal
Nitrite Negative Negative
Microscopic Examination
Red blood cells Nil /hpf 0-4
Pus cells (WBCs) 0-1 /hpf 0-9
Epithelial cells 0-1 /hpf 0-4
Crystals Absent Absent
Cast Absent Absent
Bacteria Absent Absent
Trichomonas Vaginalis Absent Absent
Yeast cells Absent Absent
Note :1.Chemical examination through Dipstick includes test methods as Protein (Protein Error Principle), Glucose (Glucose
oxidase-Peroxidase), Ketone (Legals Test), Bilirubin (Azo- Diazo reaction),Urobilinogen (Diazonium ion Reaction) Nitrite (Griess
Method). Abnormal results of chemical examination are confirmed by manual methods. 2. Negative nitrite test does not exclude the
urinary tract infections, Trace proteinuria can be seen with many physiological conditions like prolonged recumbency, exercise, high
protein diet. False positive reactions for bile pigments, proteins, glucose and nitrites can be caused by peroxidase like activity by
disinfectants, therapeutic dyes, ascorbic acid and certain drugs.3. Pre-test conditions : Void first urine ,collect mid-stream urine in
clean sterile container to avoid contamination with perineal, vaginal or urethral discharge.

-- End of Report --

Tests marked with NABL symbol are accredited by NABL vide Certificate no MC-2676; Validity till 04-04-2024

Page 6 of 6
Dr. Kush Kumar Singh
M.D (Pathology)
(DMC Reg. No. - 39780)
53 of 60

AALCP8413E
 Name : MR. SHUBHANKAR RANA
Age/Gender : 22 years / Male Ref. Doctor : SELF
Sample Type : URINE Collected : Jan 09, 2024, 02:30 p.m. MEDID : 94094
Sample ID : BT409889 Received : Jan 09, 2024, 05:03 p.m.
Client Name : 1DLDEL255 Reported : Jan 09, 2024, 06:23 p.m.

SPECIALITY - BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Nicotin/Cotinine
Cotinine(Nicotine), Urine Negative Negative
(Method: Urine, Lateral Flow Immunochromatography)
INTERPRETATION:
Urine Nicotinine screening is rapid immunoassay test based on the principle of competitive binding. It is a qualitative, preliminary analytical
method. A secondary analytical method like LCMS/ GCMS must be used to obtain a confirmed result. False negative results at any time
doesn't rule out the possibility of presence of urine nicotinine as levels may be below detection level of screening test. It needs to be
confirmed by other methods as mentioned above.

**END OF REPORT**

This is an electronically authenticated report. Report Printed Date: Jan 09, 2024, 07:42 p.m.
NOTE: Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.

54 of 60
Page 1 of 1
AALCP8413E